Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/06/2014 → 31/05/2015 |
Collaborative partners
- King's College London (lead)
- Royal Marsden NHS Foundation Trust
Validation of GPR89 as a drug discovery target for triple-negative breast cancer
- Tutt, Andrew (Primary Investigator)
- Marlow, Rebecca (Co-Investigator)
- academic, affiliated (Co-Investigator)
Project: Research